CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 2005; 55:74-108
doi: 10.3322/canjclin.55.2.74
© 2005 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Submit a Comment to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parkin, D. M.
Right arrow Articles by Pisani, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parkin, D. M.
Right arrow Articles by Pisani, P.

Global Cancer Statistics, 2002

D. Max Parkin, MD, Freddie Bray, J. Ferlay and Paola Pisani, PhD


Dr. Parkin is Chief, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Mr. Bray is Epidemiologist, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Mr. Ferlay is Informatics Officer, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.
Dr. Pisani is Scientist, Unit of Descriptive Epidemiology, International Agency for Research on Cancer, Lyon, France.

Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year 2002 are now available in the GLOBOCAN series of the International Agency for Research on Cancer. The results are presented here in summary form, including the geographic variation between 20 large "areas" of the world. Overall, there were 10.9 million new cases, 6.7 million deaths, and 24.6 million persons alive with cancer (within three years of diagnosis). The most commonly diagnosed cancers are lung (1.35 million), breast (1.15 million), and colorectal (1 million); the most common causes of cancer death are lung cancer (1.18 million deaths), stomach cancer (700,000 deaths), and liver cancer (598,000 deaths). The most prevalent cancer in the world is breast cancer (4.4 million survivors up to 5 years following diagnosis). There are striking variations in the risk of different cancers by geographic area. Most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.




This article has been cited by other articles:


Home page
 Am. J. Clin. Nutr.Home page
A. Vrieling and E. Kampman
The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature
Am. J. Clinical Nutrition, September 1, 2010; 92(3): 471 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Sakamoto, K. Effendi, and Y. Masugi
Molecular Diagnosis of Multistage Hepatocarcinogenesis
Jpn. J. Clin. Oncol., September 1, 2010; 40(9): 891 - 896.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
R. Yildiz, M. E. Kalender, F. Dane, A. Sevinc, M. Gumus, C. Camci, S. Alici, A. O. Kaya, E. Yaman, B. Ozturk, et al.
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens
Journal of Oncology Pharmacy Practice, September 1, 2010; 16(3): 173 - 178.
[Abstract] [PDF]

Home page
 Br Med BullHome page
A. C. MacKinnon, J. Kopatz, and T. Sethi
The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies
Br. Med. Bull., September 1, 2010; 95(1): 47 - 61.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. F. C. Okines, S. E. Ashley, D. Cunningham, J. Oates, A. Turner, J. Webb, C. Saffery, Y. Jo Chua, and I. Chau
Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
J. Clin. Oncol., September 1, 2010; 28(25): 3945 - 3950.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
L. G. Alexopoulos, J. Saez-Rodriguez, B. D. Cosgrove, D. A. Lauffenburger, and P. K. Sorger
Networks Inferred from Biochemical Data Reveal Profound Differences in Toll-like Receptor and Inflammatory Signaling between Normal and Transformed Hepatocytes
Mol. Cell. Proteomics, September 1, 2010; 9(9): 1849 - 1865.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
T. Goldkorn and S. Filosto
Lung Injury and Cancer: Mechanistic Insights into Ceramide and EGFR Signaling under Cigarette Smoke
Am. J. Respir. Cell Mol. Biol., September 1, 2010; 43(3): 259 - 268.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. Walter, N. Etienne-Selloum, D. Brasse, H. Khallouf, C. Bronner, M.-C. Rio, A. Beretz, and V. B. Schini-Kerth
Intake of grape-derived polyphenols reduces C26 tumor growth by inhibiting angiogenesis and inducing apoptosis
FASEB J, September 1, 2010; 24(9): 3360 - 3369.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B. Abedi-Ardekani, F. Kamangar, S. M. Hewitt, P. Hainaut, M. Sotoudeh, C. C. Abnet, P. R. Taylor, P. Boffetta, R. Malekzadeh, and S. M. Dawsey
Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran
Gut, September 1, 2010; 59(9): 1178 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Alifano, F. Souaze, S. Dupouy, S. Camilleri-Broet, M. Younes, S.-M. Ahmed-Zaid, T. Takahashi, A. Cancellieri, S. Damiani, M. Boaron, et al.
Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer
Clin. Cancer Res., September 1, 2010; 16(17): 4401 - 4410.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
Y. Guo, X. Zhang, M. Yang, X. Miao, Y. Shi, J. Yao, W. Tan, T. Sun, D. Zhao, D. Yu, et al.
Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer
J. Med. Genet., September 1, 2010; 47(9): 616 - 622.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. K. M. Lennerz, S.-H. Kim, E. L. Oates, W. J. Huh, J. M. Doherty, X. Tian, A. J. Bredemeyer, J. R. Goldenring, G. Y. Lauwers, Y.-K. Shin, et al.
The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma
Am. J. Pathol., September 1, 2010; 177(3): 1514 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. Besse, C. Massard, V. Haddad, F. Andre, A. Dunant, R. Pirker, K. A. Olaussen, E. Brambilla, P. Fouret, and J. C. Soria
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
Ann. Onc., August 26, 2010; (2010) mdq407v1.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
N. D. Freedman, A. J. Cross, K. A. McGlynn, C. C. Abnet, Y. Park, A. R. Hollenbeck, A. Schatzkin, J. E. Everhart, and R. Sinha
Association of Meat and Fat Intake With Liver Disease and Hepatocellular Carcinoma in the NIH-AARP Cohort
J Natl Cancer Inst, August 20, 2010; (2010) djq301v1.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. A. Langendijk and A. Psyrri
The prognostic significance of p16 overexpression in oropharyngeal squamous cell carcinoma: implications for treatment strategies and future clinical studies
Ann. Onc., August 17, 2010; (2010) mdq439v1.
[Full Text] [PDF]

Home page
 Am J EpidemiolHome page
M. Epplein, X.-O. Shu, Y.-B. Xiang, W.-H. Chow, G. Yang, H.-L. Li, B.-T. Ji, H. Cai, Y.-T. Gao, and W. Zheng
Fruit and Vegetable Consumption and Risk of Distal Gastric Cancer in the Shanghai Women's and Men's Health Studies
Am. J. Epidemiol., August 15, 2010; 172(4): 397 - 406.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Bourquin, P. von der Borch, C. Zoglmeier, D. Anz, N. Sandholzer, N. Suhartha, C. Wurzenberger, A. Denzel, R. Kammerer, W. Zimmermann, et al.
Efficient Eradication of Subcutaneous but Not of Autochthonous Gastric Tumors by Adoptive T Cell Transfer in an SV40 T Antigen Mouse Model
J. Immunol., August 15, 2010; 185(4): 2580 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. van Malenstein, O. Gevaert, L. Libbrecht, A. Daemen, J. Allemeersch, F. Nevens, E. Van Cutsem, D. Cassiman, B. De Moor, C. Verslype, et al.
A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma
Clin. Cancer Res., August 15, 2010; 16(16): 4278 - 4288.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ezponda, M. J. Pajares, J. Agorreta, J. I. Echeveste, J. M. Lopez-Picazo, W. Torre, R. Pio, and L. M. Montuenga
The Oncoprotein SF2/ASF Promotes Non-Small Cell Lung Cancer Survival by Enhancing Survivin Expression
Clin. Cancer Res., August 15, 2010; 16(16): 4113 - 4125.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Hendlisz, M. V. d. Eynde, M. Peeters, G. Maleux, B. Lambert, J. Vannoote, K. D. Keukeleire, C. Verslype, L. Defreyne, E. V. Cutsem, et al.
Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
J. Clin. Oncol., August 10, 2010; 28(23): 3687 - 3694.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Y. Fujiwara, K. Hotta, M. Di Maio, K. Kiura, N. Takigawa, M. Tabata, and M. Tanimoto
Time trend in treatment-related deaths of patients with advanced non-small-cell lung cancer enrolled into phase III trials of systemic treatment
Ann. Onc., August 10, 2010; (2010) mdq360v1.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Kondo, M. Morimoto, K. Numata, A. Nozaki, and K. Tanaka
Hepatic Arterial Infusion Therapy with a Fine Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Jpn. J. Clin. Oncol., August 5, 2010; (2010) hyq145v1.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
C. Liu, J. Shen, C. Pan, L. Yang, S. Mou, H. Wang, and Y. Liang
MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment of Boosting Decision Tree Model for Diagnosis of Hepatocellular Carcinoma
Am J Clin Pathol, August 1, 2010; 134(2): 235 - 241.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Antonsson, D. J. Nancarrow, I. S. Brown, A. C. Green, P. A. Drew, D. I. Watson, N. K. Hayward, D. C. Whiteman, and for the Australian Cancer Study
High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma
Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 2080 - 2087.
[Abstract] [Full Text] [PDF]

Home page
 Scand J Public HealthHome page
G. Vanagas, Z. Padaiga, J. Kurtinaitis, and Z. Logminiene
Cost-effectiveness of 12- and 15-year-old girls' human papillomavirus 16/18 population-based vaccination programmes in Lithuania
Scand J Public Health, August 1, 2010; 38(6): 639 - 647.
[Abstract] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
H.-M. Koskimaa, K. Kurvinen, S. Costa, K. Syrjanen, and S. Syrjanen
Molecular Markers Implicating Early Malignant Events in Cervical Carcinogenesis
Cancer Epidemiol. Biomarkers Prev., August 1, 2010; 19(8): 2003 - 2012.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. Frank, M. Hoffmeister, N. Klopp, T. Illig, J. Chang-Claude, and H. Brenner
Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer
Carcinogenesis, August 1, 2010; 31(8): 1381 - 1386.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. A. Gouas, H. Shi, A. H. Hautefeuille, S. L. Ortiz-Cuaran, P. C. Legros, K. J. Szymanska, O. Galy, L. A. Egevad, B. Abedi-Ardekani, K. G. Wiman, et al.
Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein
Carcinogenesis, August 1, 2010; 31(8): 1475 - 1482.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. A. Park, C. Mitchell, G. Zhang, A. Yacoub, J. Allegood, D. Haussinger, R. Reinehr, A. Larner, S. Spiegel, P. B. Fisher, et al.
Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species-Dependent Signaling Pathway
Cancer Res., August 1, 2010; 70(15): 6313 - 6324.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. J. Harrington, M. Hingorani, M. A. Tanay, J. Hickey, S. A. Bhide, P. M. Clarke, L. C. Renouf, K. Thway, A. Sibtain, I. A. McNeish, et al.
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Clin. Cancer Res., August 1, 2010; 16(15): 4005 - 4015.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
Y. Zhai, G. T. Bommer, Y. Feng, A. B. Wiese, E. R. Fearon, and K. R. Cho
Loss of Estrogen Receptor 1 Enhances Cervical Cancer Invasion
Am. J. Pathol., August 1, 2010; 177(2): 884 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. A. Park, R. Reinehr, D. Haussinger, C. Voelkel-Johnson, B. Ogretmen, A. Yacoub, S. Grant, and P. Dent
Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
Mol. Cancer Ther., August 1, 2010; 9(8): 2220 - 2231.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
C. Frederiksen, C. Qvortrup, I. J. Christensen, B. Glimelius, A. Berglund, B. V. Jensen, S. E. Nielsen, N. Keldsen, H. J. Nielsen, N. Brunner, et al.
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer
Ann. Onc., July 19, 2010; (2010) mdq354v1.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
I. Kohaar, A. Ploss, E. Korol, K. Mu, J. W. Schoggins, T. R. O'Brien, C. M. Rice, and L. Prokunina-Olsson
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
J. Virol., July 15, 2010; 84(14): 6987 - 6994.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Harada, M. Kanehira, Y. Fujisawa, R. Takata, T. Shuin, T. Miki, T. Fujioka, Y. Nakamura, and T. Katagiri
Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells
Cancer Res., July 15, 2010; 70(14): 5829 - 5839.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. Pujade-Lauraine, U. Wagner, E. Aavall-Lundqvist, V. Gebski, M. Heywood, P. A. Vasey, B. Volgger, I. Vergote, S. Pignata, A. Ferrero, et al.
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
J. Clin. Oncol., July 10, 2010; 28(20): 3323 - 3329.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
N. Altorki, M. E. Lane, T. Bauer, P. C. Lee, M. J. Guarino, H. Pass, E. Felip, N. Peylan-Ramu, A. Gurpide, F. W. Grannis, et al.
Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 1, 2010; 28(19): 3131 - 3137.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. J. Monk, T. J. Herzog, S. B. Kaye, C. N. Krasner, J. B. Vermorken, F. M. Muggia, E. Pujade-Lauraine, A. S. Lisyanskaya, A. N. Makhson, J. Rolski, et al.
Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
J. Clin. Oncol., July 1, 2010; 28(19): 3107 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Xiong, C. Wu, X. Bi, D. Yu, L. Huang, J. Xu, T. Zhang, K. Zhai, J. Chang, W. Tan, et al.
Risk of Genome-Wide Association Study-Identified Genetic Variants for Colorectal Cancer in a Chinese Population
Cancer Epidemiol. Biomarkers Prev., July 1, 2010; 19(7): 1855 - 1861.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Paccagnella, M. G. Ghi, L. Loreggian, A. Buffoli, H. Koussis, C. A. Mione, A. Bonetti, F. Campostrini, G. Gardani, A. Ardizzoia, et al.
Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
Ann. Onc., July 1, 2010; 21(7): 1515 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Zhang, J. Lu, X. Zhao, W. Wu, H. Wang, J. Lu, Q. Wu, X. Chen, W. Fan, H. Chen, et al.
A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer
Carcinogenesis, July 1, 2010; 31(7): 1251 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. L. Park, D. Bastani, B. Y. Goldstein, S.-C. Chang, W. Cozen, L. Cai, C. Cordon-Cardo, B. Ding, S. Greenland, N. He, et al.
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers
Carcinogenesis, July 1, 2010; 31(7): 1264 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
N. YAMAMOTO, T. YAMANAKA, Y. ICHINOSE, K. KUBOTA, H. SAKAI, A. GEMMA, N. SAIJO, M. FUKUOKA, and H. NIITANI
Pooled Analysis of S-1 Trials in Non-Small Cell Lung Cancer According to Histological Type
Anticancer Res, July 1, 2010; 30(7): 2985 - 2990.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
M. K. KANKURI-TAMMILEHTO, K.-O. SODERSTROM, T.-T. PELLINIEMI, T. VAHLBERG, S. O. PYRHONEN, and E. K. SALMINEN
Prognostic Evaluation of COX-2 Expression in Renal Cell Carcinoma
Anticancer Res, July 1, 2010; 30(7): 3023 - 3030.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
A.-R. Jazieh, H. Bamefleh, A. Demirkazik, R. M. Gaafar, F. B. Geara, M. Javaid, J. Khader, K. Khodadad, W. Omar, A. Saadeddin, et al.
Modification and Implementation of NCCN GuidelinesTM on Non-Small Cell Lung Cancer in the Middle East and North Africa Region
J Natl Compr Canc Netw, July 1, 2010; 8(Suppl_3): S-16 - S-21.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Compr Canc NetwHome page
W. A. Hassen, F. A. Karsan, F. Abbas, Y. Beduk, A. El-Khodary, M. Ghosn, J. Khader, R. Khauli, D. M. Rabah, A. Shamseddine, et al.
Modification and Implementation of NCCN GuidelinesTM on Prostate Cancer in the Middle East and North Africa Region
J Natl Compr Canc Netw, July 1, 2010; 8(Suppl_3): S-26 - S-28.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Z. Michaylira, G. S. Wong, C. G. Miller, C. M. Gutierrez, H. Nakagawa, R. Hammond, A. J. Klein-Szanto, J.-S. Lee, S. B. Kim, M. Herlyn, et al.
Periostin, a Cell Adhesion Molecule, Facilitates Invasion in the Tumor Microenvironment and Annotates a Novel Tumor-Invasive Signature in Esophageal Cancer
Cancer Res., July 1, 2010; 70(13): 5281 - 5292.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Kayashima, T. Toshima, S. Okano, A. Taketomi, N. Harada, Y.-i. Yamashita, Y. Tomita, K. Shirabe, and Y. Maehara
Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice
J. Immunol., July 1, 2010; 185(1): 698 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
J. Kim, J. Guan, I. Chang, X. Chen, D. Han, and C.-Y. Wang
PS-341 and Histone Deacetylase Inhibitor Synergistically Induce Apoptosis in Head and Neck Squamous Cell Carcinoma Cells
Mol. Cancer Ther., July 1, 2010; 9(7): 1977 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J.-B. Jia, W.-Q. Wang, H.-C. Sun, X.-D. Zhu, L. Liu, P.-Y. Zhuang, J.-B. Zhang, W. Zhang, H.-X. Xu, L.-Q. Kong, et al.
High Expression of Macrophage Colony-Stimulating Factor-1 Receptor in Peritumoral Liver Tissue Is Associated with Poor Outcome in Hepatocellular Carcinoma After Curative Resection
Oncologist, July 1, 2010; 15(7): 732 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
E. Pavlidou, M. Zafrakas, N. Papadakis, T. Agorastos, and A. Benos
Time trends of female breast cancer mortality in Greece during 1980-2005: a population based study
Postgrad. Med. J., July 1, 2010; 86(1017): 391 - 394.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Zigon, F. Berrino, G. Gatta, M.- J. Sanchez, B. van Dijk, E. Van Eycken, S. Francisci, and the EUROCARE Working Group
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study
Ann. Onc., June 29, 2010; (2010) mdq306v1.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
H. H. Yilmaz, N. Yazihan, D. Tunca, A. Sevinc, E. O. Olcayto, N. Ozgul, and M. Tuncer
Cancer Trends and Incidence and Mortality Patterns in Turkey
Jpn. J. Clin. Oncol., June 17, 2010; (2010) hyq075v1.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. Johansson, C. Relton, P. M. Ueland, S. E. Vollset, O. Midttun, O. Nygard, N. Slimani, P. Boffetta, M. Jenab, F. Clavel- Chapelon, et al.
Serum B Vitamin Levels and Risk of Lung Cancer
JAMA, June 16, 2010; 303(23): 2377 - 2385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Carrasco, J. Diaz, J. R. Valbuena, P. Ibanez, P. Rodriguez, G. Araya, C. Rodriguez, J. Torres, I. Duarte, E. Aravena, et al.
Overexpression of p73 as a Tissue Marker for High-Risk Gastritis
Clin. Cancer Res., June 15, 2010; 16(12): 3253 - 3259.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-Y. Yao, L. Zhang, X. Zhang, Z.-Y. He, Y. Ma, L.-J. Hui, X. Wang, and Y.-P. Hu
H3K27 Trimethylation Is an Early Epigenetic Event of p16INK4a Silencing for Regaining Tumorigenesis in Fusion Reprogrammed Hepatoma Cells
J. Biol. Chem., June 11, 2010; 285(24): 18828 - 18837.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. K. Thurlow, C. L. Pena Murillo, K. D. Hunter, F. M. Buffa, S. Patiar, G. Betts, C. M. L. West, A. L. Harris, E. K. Parkinson, P. R. Harrison, et al.
Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma
J. Clin. Oncol., June 10, 2010; 28(17): 2881 - 2888.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
I. Harirchi, S. Kolahdoozan, M. Karbakhsh, N. Chegini, S. M. Mohseni, A. Montazeri, A. J. Momtahen, A. Kashefi, and M. Ebrahimi
Twenty years of breast cancer in Iran: downstaging without a formal screening program
Ann. Onc., June 9, 2010; (2010) mdq303v1.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
J. Yamamoto, A. Saiura, R. Koga, M. Seki, M. Katori, Y. Kato, Y. Sakamoto, N. Kokudo, and T. Yamaguchi
Improved Survival of Left-sided Pancreas Cancer after Surgery
Jpn. J. Clin. Oncol., June 1, 2010; 40(6): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.-S. Lee, S.-H. Leem, S.-Y. Lee, S.-C. Kim, E.-S. Park, S.-B. Kim, S.-K. Kim, Y.-J. Kim, W.-J. Kim, and I.-S. Chu
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
J. Clin. Oncol., June 1, 2010; 28(16): 2660 - 2667.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Kanda, K. Matsuo, M. Inoue, M. Iwasaki, N. Sawada, T. Shimazu, T. Yamaji, S. Sasazuki, S. Tsugane, and for the Japan Public Health Center-based Prospecti
Association of Anthropometric Characteristics with the Risk of Malignant Lymphoma and Plasma Cell Myeloma in a Japanese Population: A Population-Based Cohort Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2010; 19(6): 1623 - 1631.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. K. Chaturvedi, C. A. Gaydos, P. Agreda, J. P. Holden, N. Chatterjee, J. J. Goedert, N. E. Caporaso, and E. A. Engels
Chlamydia pneumoniae Infection and Risk for Lung Cancer
Cancer Epidemiol. Biomarkers Prev., June 1, 2010; 19(6): 1498 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Valladares-Ayerbes, S. Diaz-Prado, M. Reboredo, V. Medina, M. J. Lorenzo-Patino, P. Iglesias-Diaz, M. Haz, S. Pertega, I. Santamarina, M. Blanco, et al.
Evaluation of Plakophilin-3 mRNA as a Biomarker for Detection of Circulating Tumor Cells in Gastrointestinal Cancer Patients
Cancer Epidemiol. Biomarkers Prev., June 1, 2010; 19(6): 1432 - 1440.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. J. Lewandowski, M. F. Mulcahy, L. M. Kulik, A. Riaz, R. K. Ryu, T. B. Baker, S. M. Ibrahim, M. I. Abecassis, F. H. Miller, K. T. Sato, et al.
Chemoembolization for Hepatocellular Carcinoma: Comprehensive Imaging and Survival Analysis in a 172-Patient Cohort
Radiology, June 1, 2010; 255(3): 955 - 965.
[Abstract] [Full Text] [PDF]

Home page
 Global Health PromotionHome page
S. Chirwa, M. Mwanahamuntu, S. Kapambwe, G. Mkumba, J. Stringer, V. Sahasrabuddhe, K. Pfaendler, and G. Parham
Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators
Global Health Promotion, June 1, 2010; 17(2_suppl): 47 - 50.
[Abstract] [PDF]

Home page
 CarcinogenesisHome page
S. Haruki, I. Imoto, K.-i. Kozaki, T. Matsui, H. Kawachi, S. Komatsu, T. Muramatsu, Y. Shimada, T. Kawano, and J. Inazawa
Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma
Carcinogenesis, June 1, 2010; 31(6): 1027 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Dong, J. Dai, Y. Shu, S. Pan, L. Xu, W. Chen, Y. Wang, G. Jin, H. Ma, M. Zhang, et al.
Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population
Carcinogenesis, June 1, 2010; 31(6): 1080 - 1086.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
H. Brenner, L. Altenhofen, and M. Hoffmeister
Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis
Ann Intern Med, June 1, 2010; 152(11): 697 - 703.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
A. SPATHIS, J. GEORGOULAKIS, P. FOUKAS, M. KEFALA, K. LEVENTAKOS, A. MACHAIRAS, I. PANAYIOTIDES, and P. KARAKITSOS
KRAS and BRAF Mutation Analysis from Liquid-based Cytology Brushings of Colorectal Carcinoma in Comparison with Formalin-fixed, Paraffin-embedded Tissue
Anticancer Res, June 1, 2010; 30(6): 1969 - 1975.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
M. PRIVAT, C. AUBEL, S. ARNOULD, Y. COMMUNAL, M. FERRARA, and Y.-J. BIGNON
AKT and p21WAF1/CIP1 as Potential Genistein Targets in BRCA1-mutant Human Breast Cancer Cell Lines
Anticancer Res, June 1, 2010; 30(6): 2049 - 2054.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
K. DEGUCHI, D. ICHIKAWA, K. SOGA, K. WATANABE, T. KOSUGA, H. TAKESHITA, H. KONISHI, R. MORIMURA, M. TSUJIURA, S. KOMATSU, et al.
Clinical Significance of Vascular Endothelial Growth Factors C and D and Chemokine Receptor CCR7 in Gastric Cancer
Anticancer Res, June 1, 2010; 30(6): 2361 - 2366.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
J. SZKANDERA, G. KNECHTEL, M. STOTZ, G. HOFMANN, U. LANGSENLEHNER, P. KRIPPL, T. LANGSENLEHNER, D. DEHCHAMANI, H. SAMONIGG, W. RENNER, et al.
Association of Hypoxia-inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis
Anticancer Res, June 1, 2010; 30(6): 2393 - 2397.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Prevention ResearchHome page
A. Bishayee, K. F. Barnes, D. Bhatia, A. S. Darvesh, and R. T. Carroll
Resveratrol Suppresses Oxidative Stress and Inflammatory Response in Diethylnitrosamine-Initiated Rat Hepatocarcinogenesis
Cancer Prevention Research, June 1, 2010; 3(6): 753 - 763.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. C. M. Zuiverloon, M. N. M. van der Aa, T. H. van der Kwast, E. W. Steyerberg, H. F. Lingsma, C. H. Bangma, and E. C. Zwarthoff
Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
Clin. Cancer Res., June 1, 2010; 16(11): 3011 - 3018.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
C. Shaha, R. Tripathi, and D. P. Mishra
Male germ cell apoptosis: regulation and biology
Phil Trans R Soc B, May 27, 2010; 365(1546): 1501 - 1515.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. C. Soria, C. Massard, and T. Le Chevalier
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
Ann. Onc., May 23, 2010; (2010) mdq204v1.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. Amir, O. C. Freedman, B. Seruga, and D. G. Evans
Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment Models
J Natl Cancer Inst, May 19, 2010; 102(10): 680 - 691.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. G. Hocking, P. Hu, M. M. Oken, S. D. Winslow, P. A. Kvale, P. C. Prorok, L. R. Ragard, J. Commins, D. A. Lynch, G. L. Andriole, et al.
Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
J Natl Cancer Inst, May 19, 2010; 102(10): 722 - 731.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
C. Johnson, K. Sanders, and H. Fan
Jaagsiekte Sheep Retrovirus Transformation in Madin-Darby Canine Kidney Epithelial Cell Three-Dimensional Culture
J. Virol., May 15, 2010; 84(10): 5379 - 5390.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
C. Yoo, J. E. Kim, J. L. Lee, J. H. Ahn, D. H. Lee, J. S. Lee, S. Na, C. S. Kim, J. H. Hong, B. Hong, et al.
The Efficacy and Safety of Sunitinib in Korean Patients with Advanced Renal Cell Carcinoma: High Incidence of Toxicity Leads to Frequent Dose Reduction
Jpn. J. Clin. Oncol., May 10, 2010; (2010) hyq073v1.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
A. A. Arslan, K. J. Helzlsouer, C. Kooperberg, X. O. Shu, E. Steplowski, H. B. Bueno-de-Mesquita, C. S. Fuchs, M. D. Gross, E. J. Jacobs, A. Z. LaCroix, et al.
Anthropometric Measures, Body Mass Index, and Pancreatic Cancer: A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan)
Arch Intern Med, May 10, 2010; 170(9): 791 - 802.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
W. F. Anderson, M. C. Camargo, J. F. Fraumeni Jr, P. Correa, P. S. Rosenberg, and C. S. Rabkin
Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
JAMA, May 5, 2010; 303(17): 1723 - 1728.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. M. Azzato, J. Tyrer, P. A. Fasching, M. W. Beckmann, A. B. Ekici, R. Schulz-Wendtland, S. E. Bojesen, B. G. Nordestgaard, H. Flyger, R. L. Milne, et al.
Association Between a Germline OCA2 Polymorphism at Chromosome 15q13.1 and Estrogen Receptor-Negative Breast Cancer Survival
J Natl Cancer Inst, May 5, 2010; 102(9): 650 - 662.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. H. Guo, X. Zhang, H. Z. Zhang, H. L. Lin, Y. Feng, J. Y. Shao, W. L. Huang, H. F. Kung, and M. S. Zeng
Low expression of Mel-18 predicts poor prognosis in patients with breast cancer
Ann. Onc., May 5, 2010; (2010) mdq241v1.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. K. Yoo, L. Emdad, R. Gredler, C. Fuller, C. I. Dumur, K. H. Jones, C. Jackson-Cook, Z.-z. Su, D. Chen, U. H. Saxena, et al.
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma
PNAS, May 4, 2010; 107(18): 8357 - 8362.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. C. Chuang, Y. C. A. Lee, M. Hashibe, M. Dai, T. Zheng, and P. Boffetta
Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Meta-analysis
Cancer Epidemiol. Biomarkers Prev., May 1, 2010; 19(5): 1261 - 1268.
[Abstract] [Full Text] [PDF]

Home page
 Hum Exp ToxicolHome page
J. S. Yang, C. C. Wu, C. L. Kuo, C. C. Yeh, F. S. Chueh, C. K. Hsu, C. K. Wang, C. Y. Chang, S. W. Ip, Y. M. Hsu, et al.
Solannm lyratum extract affected immune response in normal and leukemia murine animal in vivo
Human and Experimental Toxicology, May 1, 2010; 29(5): 359 - 367.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
J. Kim, S. Park, and B. H. Nam
Gastric cancer and salt preference: a population-based cohort study in Korea
Am. J. Clinical Nutrition, May 1, 2010; 91(5): 1289 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
C. Torre, S. J. Wang, W. Xia, and L. Y. W. Bourguignon
Reduction of Hyaluronan-CD44-Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase Signaling
Arch Otolaryngol Head Neck Surg, May 1, 2010; 136(5): 493 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. Glimelius, M. Lahn, S. Gawande, A. Cleverly, C. Darstein, L. Musib, Y. Liu, K. L. Spindler, J. E. Frodin, A. Berglund, et al.
A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer
Ann. Onc., May 1, 2010; 21(5): 1020 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
P. Schatz, D. Dietrich, T. Koenig, M. Burger, A. Lukas, I. Fuhrmann, G. Kristiansen, R. Stoehr, M. Schuster, R. Lesche, et al.
Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation
J. Mol. Diagn., May 1, 2010; 12(3): 345 - 353.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by American Cancer Society.